|
Status |
Public on Dec 24, 2019 |
Title |
C2C12_H3K27Ac_DM_shCas |
Sample type |
SRA |
|
|
Source name |
C2C12_H3K27Ac_DM_shCas
|
Organism |
Mus musculus |
Characteristics |
cell type: Differentiated C2C12 chip antibody: H3K27ac (Abcam, ab4729) genotype: shCas
|
Treatment protocol |
ChIP experiment was performed after shCtrl and shCasz1 C2C12 cells being cultured in differentiation medium (DMEM containing 2% horse serum) for 48 hr.
|
Growth protocol |
C2C12 cells are cultured in RPMI 1640 containing 10% FBS.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Lysates were clarified from sonicated nuclei and histone-DNA complexes were isolated with antibody following the Active Motif's instructions of the ChIP-IT High Sensitivity Kit. Libraries were prepared according to Illumina's TruSeq ChIP Sample Preparation Guide.
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina NextSeq 500 |
|
|
Data processing |
Basecalls performed using CASAVA version 1.4 ChIP-seq reads were aligned to the mm10 genome using bwa and then use the MACS2 for peak calling Genome_build: mm10 Supplementary_files_format_and_content: bigWig files were generated using deeptools. The coverage is calculated as the number of reads per bin.
|
|
|
Submission date |
Feb 06, 2019 |
Last update date |
Dec 26, 2019 |
Contact name |
Jack Shern |
Organization name |
NCI
|
Lab |
POB
|
Street address |
10 Center drive
|
City |
bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platform ID |
GPL19057 |
Series (2) |
GSE126141 |
The affect of loss of Casz1 in C2C12 cells on super-enhancers |
GSE126147 |
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation |
|
Relations |
BioSample |
SAMN10880542 |
SRA |
SRX5341958 |